Alkenylsilylazetidinone intermediates for carbapenems

Abstract: An intermediate for synthesizing carbapenems is produced through 1) a reaction of 4-(leaving group substituted)-2-azetidinone ( I ) with (alk-2-enyl)halosilane ( II ) to afford 4-(leaving group substituted)-1-(alk-2-enyl)silyl-2-azetidinone ( III ) and then 2) a reaction of the product 4-(leaving group substituted)-1-­ (alk-2-enyl)silyl-2-azetidinone ( III ) with acid to give the corresponding 4-(alk-2-enyl)-2-azetidinone ( IV ). (The symbols are defined in the specification)

Description: This invention relates to a stereospecific process for preparing an intermediate for synthesizing beta-lactam compounds which comprises the following two novel reactions, namely : 1) reaction of 4-(leaving group substituted)-2-azetidinone ( I ) with (alk-2-enyl)halosilane ( II ) to afford 4-(leaving group substituted)-1-(alk-2-enyl)silyl-2-azetidinone ( III ) and 2) reaction of 4-(leaving group substituted)-1-(alk-2-enyl)-silyl-2-azetidinone ( III ) with acid to give the corresponding 4-(alk-2-enyl)-2-azetidinone ( IV ). More specifically this invention provides: (1) a new process for producing 4-(leaving group substituted)-1-(alk-2-enyl)silyl-2-azetidinone ( III ) by treating 4-(leaving group substituted)-2-azetidinone ( I ) with (alk-2-enyl)halosilane ( II ); (2) a new process for producing 4-(alk-2-enyl)-2-azetidinone ( IV ) by treating an 4-(leaving group substituted)-1-(alk-2-enyl)-silyl-2-azetidinone ( III ) with acid; and (3) a new 4-(leaving group substituted)-1-(alk-2-enyl)silyl-2-azetidinone ( III ). (wherein, R is hydrogen or optionally substituted alkyl; R¹ is a leaving group; R² and R³ each is hydrogen or optionally substituted alkyl or monocycl i c aryl; R⁴ is hydrogen, optionally substituted alkyl, or a nucleophilic group; R⁵ and R⁶ each is hydrogen, optionally substituted alkyl or mono or di-cyclic 5 to 6 membered carbo- or heterocyclic aryl, or optionally protected carboxy; R⁷ and R⁸ each is hydrogen, halogen, or optionally substituted alkyl or mono or di- cyclic 5 to 6 membered carbo- or hetero- cyclic aryl; and Hal is halogen or a pseudo halogen), [Background of this invention] 1-Alkylcarbapenems are in a sector of the recent topics in the field of chemotherapy. A promising known method for preparing a key intermediate, 4-(alk-2-enyl)-2-azetidinone ( IV ), is non-stereospecific (e.g., J. Org. Chem ., 50 , 3438 (1985)) and the stereochemistry of the products can not be controlled to result in poor operability of the process and low yield of the objective 1-alkylcarbapenems. [Summary of the invention] The object of the present invention is to provide a stereospecific and industrial method by allylic rearrangement for producing 4-(alk-2-enyl)-2-azetidinone ( IV ), a key intermediate for producing antibacterial 1β-alkylcarbapenems and thus solving the problem found in the prior arts. Thus, the present invention provides a process for preparing a 1-(alk-2-enyl)silyl-2-azetidinone of the following formula (III) : which comprises treating a 2-azetidinone of the following formula (I) with an (alk-2-enyl)halo-silane of the following formula (II) : wherein R is hydrogen or a optionally substituted alkyl group selected from : 1C to 8C alkyl; 1C to 8C hydroxyalkyl; 1C to 8C haloalkyl; 4C to 8C dioxolyl; the hydroxy in the said hydroxyalkyl being optionally protected by an hydroxy protective group selected from 1C to 8C acyl, oxycarbonyl which is a group of carbonic acid half ester, 2C to 8C ether forming group, 3C to 18C silyl and 7C to 19C reactive aralkyl; R1 is a leaving group selected from : hydroxy, optionally substituted 1C to 8C alkanoyloxy, wherein the alkyl part of the group is straight, branched or cyclic alkyl and the substituents are selected from straight, branched, or cyclic alkyl, alkenyl, alkinyl, aralkyl, aryl, heterocyclyl, carboxylic acyl, carbamoyl, carboxy, protected carboxy, cyano, amino, acylamino, guanidyl, ureido, alkylamino, dialkylamino, isothiocyano, isocyano, nitro, nitroso, hydroxy, alkoxy, aryloxy, hetero-cyclyloxy, cyanato, oxo, carboxylic acyloxy, sulfonic acyloxy, phosphoric acyloxy, mercapto, alkylthio, alkylsulfonyl, arylthio, arylsulfonyl, heterocyclylthio, heterocyclylsulfonyl, acylthio, thioxo, sulfo, sulfamoyl, halogen, silyl and stannyl; 7C to 15C aroyloxy, 1C to 8C alkylsulfinyl, 6C to 10C arylsulfinyloxy, 1C to 8C alkylsulfonyloxy, 6C to 10C arylsulfonyloxy, 1C to 15C acyloxy and halogen; R² and R³ each is hydrogen or an optionally substituted 1C to 8C alkyl or 6C to 8C monocyclic aryl group, wherein the alkyl part of the said alkyl is straight, branched or cyclic alkyl and the substituents of said alkyl or aryl group are selected from halogen, nitrile, isonitrile, hydroxy, 1C to 8C alkoxy, 6C to 10C aryloxy, 1C to 10C acyloxy, 7C to 19C aralkoxy, oxo, 6C to 10C arylthio, 1C to 8C alkylthio, amino, 1C to 8C mono- or di-alkylamino, tetrazol-1-yl, triazol-1-yl, 1C to 10C mono-or poly-cyclic arylinio; R⁴ is hydrogen, 1C to 8C alkyl or a 1C to 8C alkyl substituted by a nucleophilic group selected from : halogen, hydroxy, 1C to 8C alkoxy, 6C to 10C aryloxy, 1C to 10C acyloxy, 7C to 19C aralkoxy, oxo, 6C to 10C arylthio, 1C to 8C alkylthio, amino, 1C to 8C mono or di-alkylamino, tetrazol-1-yl, triazol-1-yl, 1C to 8C mono or poly-cyclic arylinio, 1C to 8C alkyl, 3C to 12C alkenyl, 7C to 19C aralkyl, 6C to 12C aryl, carboxy, 1C to 8C alkoxycarbonyl, 3C to 12C alkenyloxycarbonyl, 8C to 20C aralkoxy-carbonyl, 6C to 12C aryloxycarbonyl, 1C to 12C aminooxycarbonyl, 3C to 12C silyloxycarbonyl, 3C to 12C stannyloxycarbonyl, 2C to 15C 1-oxygenated alkoxycarbonyl, 3C to 15C 1-alkoxycarbonyloxyalkyl, 2C to 8C alkoxyakyl and 4C to 8C 2-oxacycloalkyl; R⁵ and R⁶ each is hydrogen; optionally substituted 1C to 10C alkyl, or optionally substituted mono or di-cyclic 5 to 6 membered carbo- or heterocyclic aryl group, wherein the alkyl part of the said alkyl group is straight, branched or cyclic and the substituents of said alkyl or aryl group are selected from straight, branched, or cyclic alkyl, alkenyl, alkinyl, aralkyl, aryl, heterocyclyl, carboxylic acyl, carbamoyl, carboxy, protected carboxy, cyano, amino, acylamino, guanidyl, ureido, alkylamino, dialkylamino, isothiocyano, isocyano, nitro, nitroso, hyroxy, alkoxy, aryloxy, heterocyclyloxy, cyanato, oxo, carboxylic acyloxy, sulfonic acyloxy, phosphoric acyloxy, mercapto, alkylthio, alkylsulfonyl, arylthio, arylsulfonyl, heterocyclylthio, heterocyclysulfonyl, acylthio, thioxo, sulfo, sulfamoyl and from halogen, silyl and stannyl; carboxy or a protected carboxy group selected from chloroethyl ester, methanesulfonylethyl ester, aralkyl ester, alkenyl ester and ester forming protected carboxy; R⁷ and R⁸ each is hydrogen, optionally substituted 1C to 8C alkyl or optionally substituted 1C to 10C mono- or di-cyclic 5 to 6 membered carbo- or hetero-cyclic aryl group, wherein the alkyl part of said alkyl group is straight, branched or cyclic alkyl and the substituents of said alkyl or aryl group are selected from straight, branched, or cyclic alkyl, alkenyl, alkinyl, aralkyl, aryl, heterocyclylc, carboxylic acyl, carbamoyl, carboxy, protected carboxy, cyano, amino, acylamino, guanidyl, ureido, alkylamino, dialkylamino, isothiocyano, isocyano, nitro, nitroso, hydroxy, alkoxy, aryloxy, heterocyclyloxy, cyanato, oxo, carboxylic acyloxy, sulfonic acyloxy, phosphoric acyloxy, mercapto, alkylthio, alkylsulfonyl, arylthio, arylsulfonyl, heterocyclylthio, heterocyclylsulfonyl, acylthio, thioxo, sulfo, sulfamoyl and from halogen, silyl and stannyl; and Hal is halogen or a pseudo halogen; and wherein R², R³, R⁴, R⁵ and R⁶ can be combined directly or through a hetero atom to form a part of cyclic structure. The reaction of 4-(leaving group substituted)-2-azetidinone ( I ) and (alk-2-enyl)halosilane ( II ) in the presence of an acid scavenger affords the novel 4-(leaving group substituted)-1-(alk-2-enyl)silyl-2-azetidinone ( III ) under a mild condition. This product ( III ) gives the corresponding 4-(alk-2-enyl)-2-azetidinone ( IV ) by the action of acid. Thus, the present invention provides also a process for preparing a 4-(alk-2-enyl)-2-azetidinone of the following formula ( IV ) which comprises treating a 1-(alk-2-enyl)silyl-2-azetidinone of the formula (III) specified above with acid in an inert solvent wherein R, R², R³, R⁴, R⁵ and R⁶ are as defined above and the 1-(alk-2-enyl)silyl-2-azetidinone of the following formula (III). wherein R, R¹, R², R³, R⁴, R⁵, R⁶, R⁷, and R⁸ are as defined above. This product ( IV ) is a starting material for synthesizing 1-alkylcarbapenem. The novel C to C bond formation proceeds intramolecularly but not intermolecularly under the same condition. Thus, 4-(leaving group substituted)-2-azetidinone ( I ) and (alk-2-enyl)halosilane ( II ) in the presence of zinc bromide failed to react giving 4-(alk-2-enyl)-2-azetidinone ( IV ). Furthermore, the stereospecific intramolecular alkenylation of 4-(leaving group substituted)-1-(alk-2-enyl)silyl-2-azetidinone ( III ) with acid is found to occur from the side opposite to the 3-side chain irrespective of the configuration of the 4-leaving group. As a result, 4-(alk-2-enyl)-2-azetidinone ( IV ) produced by the fissions of N to Si bond and Si to C bond with acid and subsequent aqueous work-up has the preferable 3,4-trans stereochemistry. The intermolecular rearrangement of the 4-(leaving group substituted)-1-(alk-2-enyl)silyl-2-azetidinone ( II ) to give 4-(alk-2-enyl)-2-azetidinone ( IV ) is a sterically controlled sigma-tropic reaction and therefore the stereochemistry of the product is uniform. Thus, this invention improve the production of objective carbapenem (e.g., with respect to the handling of the reaction mixture, especially purification, separation of isomer, time, and reagent in the work up) as compared with the prior art methods utilizing intermolecular reactions. This invention is especially suitable for the following route for producing 1β-methylcarbapenems: Butadiene and dimethyldichlorosilane are reacted to afford dimethyl((Z)-but-2-enyl)chlorosilane ( II ) (e.g., Izuvestia Academia Nauka USSR (Chemistry) , 1980 , page 2). This but-2-enylhalosilane ( II ) is reacted with a commercially available 3-(1-silyloxyethyl)-4-acetoxy-2-azetidinone ( I ) to produce 4-(leaving group substituted)-1-(alk-2-enyl)-silyl-2-azetidinone ( III ). This 4-(leaving group substituted)-1-(alk-2-enyl)silyl-2-azetidinone ( III ) is treated with acid e.g., zinc bromide to obtain 4-(alk-2-enyl)-2-azetidinone ( IV ). The 4-(alk-2-enyl)-2-azetidinone ( IV ) can be converted into stereochemically highly pure carbapenems by a known method (e.g., Japanese Patent Application No. 60-260731). The following illustrates the groups in the formula: R is hydrogen, optionally substituted alkyl. Representative are well known in carbapenem and penem compounds including hydrogen, 1C to 8C alkyl (e.g., methyl, ethyl, propyl), 1C to 8C hydroxyalkyl (e.g., hydroxymethyl, 1-hydroxyethyl, 1-hydroxypropyl, 2-hydroxyisopropyl), 1C to 8C haloalkyl (e.g., fluoromethyl, chloromethyl, 1-fluoroethyl, 2-fluoroisopropyl, trifluoromethyl), 4C to 8C dioxolyl [e.g., 2-oxo-4-alkyl(e.g., methyl, ethyl, and propyl-dioxolyl]. The hydroxy in the said hydroxyalkyl can be protected conventionally by the following hydroxy protective group, for example, 1C to 8C acyl, oxycarbonyl which is a group of carbonic acid half ester (with e.g., 2C to 10C alkyl, chloroalkyl, benzyl, o- or p-nitrobenzyl, and p-methoxybenzyl, allyl, 2C to 8C ether forming group (e.g., methoxymethyl, methoxyethoxymethyl, tetrahydrofuranyl, tetrahydropyranyl), 3C to 18C silyl (e.g., trimethylsilyl, triethylsilyl, dimethylphenylsilyl, diphenyl-t-butylsilyl, triphenylsilyl, dimethyl-t-pentylsilyl), and 7C to 19C reactive aralkyl (e.g., triphenylmethyl). R¹ is a leaving group. Representative are hydroxy, optionally substituted 1C to 8C alkanoyloxy, 7C to 15C aroyloxy, 1C to 8C alkylsulfinyl, 6C to 10C arylsulfinyloxy, 1C to 8C alkylsulfonyloxy, 6C to 10C arylsulfonyloxy, 1C to 15C acyloxy and halogen (e.g., chlorine, fluorine, bromine). R² and R³ each is hydrogen, optionally substituted alkyl, or aryl. Representative are 1C to 8C alkyl (e.g., methyl, ethyl, propyl), 6C to 8C monocyclic aryl (e.g., phenyl, tolyl), optionally substituted by, e.g., the oxygen-, sulfur-, or nitrogen-function as explained below including nitrile, isonitrile and halogen. R⁴ is hydrogen, alkyl, or substituted alkyl. Representative are hydrogen, 1C to 8C alkyl, and 1C to 8C alkyl substituted by a nucleophilic group known as a 3-substituents of cephalosporins, e.g., 1C to 19C nucleophilic group, for example, halogen = halo (e.g., fluoro, chloro, bromo, iodo), oxygen function = hydroxy, 1C to 8C alkoxy, 6C to 10C aryloxy, 1C to 10C acyloxy (e.g., alkanoyl, substituted alkanoyl, aroyl, carbamoyl, substituted carbamoyl, mono- or di-alkylcarbamoyl), 7C to 19C aralkoxy (e.g., p-methoxybenzyloxy, benzhydryloxy, trityloxy), oxo, or the like: sulfur function = 6C to 10C arylthio (e.g., phenyl, naphthyl, indenyl), mono- or di-cyclic heterocyclylthio (e.g., furyl, thienyl, pyrrolyl, oxazolyl, thiazolyl, imidazolyl, oxadiazolyl, thiadiazolyl, triazolyl, thiatriazolyl, tetrazolyl, pyridyl, pyranyl, indolyl, benzofuryl, benzothienyl, benzoimidazolyl, benzothiazolyl, benzopyrazinyl, quinolyl, pyridopyridyl), 1C to 8C alkylthio (e.g., ethyl, fluoroethyl, fluorovinyl), or the like; nitrogen function = amino, 1C to 8C mono- or di-alkylamino tetrazol-1-yl, triazol-1-yl, 1C to 10C mono- or poly-cyclic arylinio (e.g., pyridinio, carboxypyridinio, carbamoylpyridinio, picolinio, cyclopentenopyridinio, cyclohexenopyridinio, quinolinio, 1-lower alkylimidazolidinio, cycloalkanopyridinio, 1-lower alkyltriazolidinio, piperidinio, pyrrolidinio, quinuclidinio), or the like; carbon function = 1C to 8C alkyl (e.g., methyl, methoxymethyl, ethyl, ethoxymethyl, iodoethyl, propyl, isopropyl, butyl, isobutyl, ethoxyethyl, methylthioethyl, methanesulfonylethyl, trichloroethyl, t-butyl), 3C to 12C alkenyl (e.g ., propenyl, allyl, prenyl, hexenyl, phenylpropenyl, dimethylhexenyl, 2-oxo-1, 3-dioxolylmethyl), 7C to 19C aralkyl (e.g., benzyl, methylbenzyl, dimethylbenzyl, methoxybenzyl, ethoxybenzyl, nitrobenzyl, aminobenzyl, diphenylmethyl, phenylethyl, trityl, di-t-butylhydroxybenzyl, phthalidyl, phenacyl), 6C to 12C aryl (e.g., phenyl, tolyl, diisopropylphenyl, xylyl, trichlorophenyl, pentachlorophenyl, indanyl), carboxy, 1C to 8C alkyloxycarbonyl where alkyl is, e.g., methyl, methoxymethyl, ethyl, ethoxymethyl, iodoethyl, propyl, isopropyl, butyl, isobutyl, ethoxyethyl, methylthioethyl, methanesulfonylethyl, trichloroethyl, t-butyl; 3C to 12C alkenyloxycarbonyl, in which alkenyl is, e.g., propenyl, allyl, prenyl, hexenyl, phenylpropenyl, dimethylhexenyl, 2-oxo-1,3-dioxolylmethyl; 8C to 20C aralkoxycarbonyl where aralkyl is, e.g., benzyl, methylbenzyl, dimethylbenzyl, methoxybenzyl, ethoxybenzyl, nitrobenzyl, aminobenzyl, diphenylmethyl, phenylethyl, trityl, di-t-butylhydroxybenzyl, phthalidyl, phenacyl; 6C to 12C aryloxycarbonyl where is, e.g., phenyl, tolyl, diisopropylphenyl, xylyl, trichlorophenyl, pentachlorophenyl, indanyl; 1C to 12C aminooxycarbonyl (forming an ester with e.g., acetone oxime, acetophenone oxyme, acetaldoxime, N-hydroxysuccinimide, N-hydroxyphthalimide), 3C to 12C silyloxycarbonyl where silyl is, e.g., trimethylsilyl, dimethylmethoxysilyl, t-butyldimethylsilyl, 3C to 12C stannyloxycarbonyl where stannyl is trimethylstannyl; 2C to 15C 1-oxygenated alkoxycarbonyl where 1-oxygenated alkyl is, for example, straight, branched, cyclic or partly cyclic alkanoyloxyalkyl (e.g., acetoxymethyl, acetoxyethyl, propionyloxymethyl, pivaloyloxymethyl, cyclohexanecarbonyloxyethyl), 3C to 15C 1-alkoxycarbonyloxyalkyl (e.g., ethoxycarbonyloxyethyl, isopropoxycarbonyloxyethyl, t-butoxycarbonyloxyethyl, isopentyloxycarbonyloxypropyl, cyclohexylmethoxycarbonyloxyethyl, bornyloxycarbonyloxymethyl), 2C to 8C alkoxyalkyl (e.g., methoxymethyl, methoxyethyl), 4C to 8C 2-oxacycloalkyl (e.g., tetrahydrofuranyl, tetrahydropyranyl), or the like. R⁵ and R⁶ are the same or different and can be hydrogen, optionally substituted alkyl or aryl, or optionally protected carboxy. Representative are 1C to 10C alkyl (e.g., methyl, ethyl, propyl, isopropyl, cyclopropyl, butyl, isobutyl, t-butyl, cyclobutyl, cyclopropylmethyl, pentyl, isopentyl, neopentyl, cyclopentyl, cyclopropylethyl, hexyl, cyclohexyl, cyclopentylmethyl, heptyl, cycloheptyl, cyclopentylethyl, cyclohexylmethyl, octyl, cyclooctyl, cyclohexylethyl, nonyl, dodecyl), carboxy, protected carboxy [for example, 2C to 10C alkyl ester (e.g., methyl, ethyl, propyl, isopropyl, cyclopropyl, butyl, isobutyl, t-butyl, cyclobutyl, cyclopropylmethyl, pentyl) ester, substituted alkyl ester (e.g., chloroethyl, methanesulfonylethyl ester), aralkyl ester (e.g., benzyl, p-nitrobenzyl, p-methoxybenzyl, o-nitrobenzyl), or alkenyl ester (e.g., prenyl, allyl) ester forming protected carboxy], and the like. R⁷ and R⁸ are the same or different and can be hydrogen. halogen, or optionally substituted alkyl or aryl. Representative are 1C to 8C alkyl (e.g., methyl, ethyl, propyl, isopropyl, cyclopropyl, butyl, isobutyl, t-butyl, cyclobutyl, cyclopropylmethyl, pentyl, isopentyl, neopentyl, cyclopentyl, cyclopropylethyl, hexyl, cyclohexyl), 1C to 8C substituted alkyl (e.g., chloroethyl, methanesulfonylethyl), 1 to 10C mono- or di-cyclic 5 to 6 membered ring carbo- or hetero-cyclic aryl (e.g., phenyl, naphthyl, indenyl, furyl, thienyl, pyrrolyl, oxazolyl, thiazolyl, imidazolyl, oxadiazolyl, thiadiazolyl, triazolyl, thiatriazolyl, tetrazolyl, pridyl, pyranyl, indolyl, benzofuryl, benzothienyl, benzoimidazolyl, benzothiazolyl, benzothienyl, benzoimidazolyl, benzothiazolyl, benzopyradinyl, quinolyl, pyridopyridyl), halogen (e.g., fluorine, chlorine, bromine, iodine, pseudohalogen), and the like. Hal is halogen. Representative are chlorine, bromine, and iodine, and including a pseudohalogen (e.g., lower alkanesulfonyl, benzenesulfonyl, substituted benzenesulfonyl). The said R², R³, R⁴, R⁵, and R⁶ can be combined directly or through a hetero atom to form a part of cyclic structure. The substituent in the said R, R¹, R², R³, R⁴, R⁵, R⁶, and R⁷ 1 or more the same or different substituents. It may be one of the substituents as given below. The alkyl part of the said groups is straight, branched or cyclic alkyl. Representative alkyls are methyl, ethyl, propyl, isopropyl, cyclopropyl, butyl, isobutyl, t-butyl, cyclobutyl, cyclopropylmethyl, pentyl, isopentyl, neopentyl, cyclopentyl, cyclopropylethyl, hexyl, cyclohexyl, cyclopentylmethyl, heptyl, cycloheptyl, cyclopentylethyl, cyclohexylmethyl, octyl, cyclooctyl, cyclohexylethyl, nonyl, dodecyl, and the like. These may have a substituent as illustrated below. The aralkyl part of the groups is a combination of a alkyl part and aryl part. Representative aralkyls are benzyl, phenylethyl, phenylpropyl, phenylisopropyl, naphthylmethyl, furylmethyl, thienylpropyl, oxazolylmethyl, thiazolylmethyl, imidazolylmethyl, triazolylmethyl, pyridylmethyl, indolylmethyl, benzoimidazolylethyl, benzothiazolylmethyl, quinolyl, and the like. These may have a substituent as illustrated below. The acyl part of the groups is a straight, branched, or cyclic alkanoyl, mono- or di-cyclic, optionally heterocyclic aroyl, aralkanoyl, arylalkenoyl, alkylsulfonyl, arylsulfonyl, carbamoyl, carbalkoxy, carbaralkoxy, sulfo, and the like acyl groups. These acyl may have a substituent as illustrated at the item of alkyl. The aryl part is mono- or di-cyclic 5- to 6-membered carbo- or hetero-cyclic aryl. This heterocyclic group may have oxygen, nitrogen, or sulfur as a heteroatom. Representative aryls are phenyl, naphthyl, indenyl, furyl, thienyl, pyrrolyl, oxazolyl, thiazolyl, imidazolyl, oxadiazolyl, thiadiazolyl, triazolyl, thiatriazolyl, tetrazolyl, pyridyl, pyranyl, indolyl, benzofuryl, benzothienyl, benzoimidazolyl, benzothiazolyl, benzopyradinyl, quinolyl, pyridopyridyl, and the like. These may have a substituent as illustrated below. The representative substituents which can be combined with the said groups include a carbon function (e.g., straight, branched or cyclic alkyl, alkenyl, alkinyl, aralkyl, aryl, heterocyclyl, carboxylic acyl, carbamoyl, carboxy, protected carboxy, cyano), nitrogen function (e.g., amino, acylamino, guanidyl, ureido, alkylamino, dialkylamino, isothiocyano, isocyano, nitro, nitroso), oxygen function (e.g., hydroxy, alkoxy, aryloxy, heterocyclyloxy, cyanato, oxo, carboxylic acyloxy, sulfonic acyloxy, phosphoric acyloxy), sulfur function (e.g., mercapto, alkylthio, alkylsulfonyl, arylthio, arylsulfonyl, heterocyclylthio, heterocyclylsulfonyl, acylthio, thioxo, sulfo, sulfamoyl), halogen (e.g., fluoro, chloro, bromo, iodo), silyl (e.g., trialkylsilyl, dialkylalkoxysilyl), and stannyl (e.g., trialkylstannyl). The said carbon numbers do not include that of protective group. [The reactions of this invention] (1) N-Silyl introduction The reaction of 4-(leaving group substituted)-2-azetidinone ( I ) with (alk-2-enyl)halosilane ( II ) in an inert solvent (e.g., hydrocarbon, ether, ester, halohydrocarbon solvent) in the presence of a condensing reagent affords the corresponding 4-(leaving group substituted)-1-(alk-2-enyl)silyl-2-azetidinone ( III ). Generally, the reaction of 4-(leaving group substituted)-2-azetidinone ( I ) with 1 to 2 equivalents of (alk-2-enyl)halosilane ( II ) at -20 to 40°C completes within a time between 30 minutes and 25 hours. The yield is about 80 to 95 %. Here, the condensing reagent can preferably be 1 to 5 equivalents of a tertiary amine, for example, tri(1C to 8C alkyl)amine (e.g., triethylamine, tri(2-hydroxyethyl)amine, triton B, N,N-dimethylaniline), an aromatic base (e.g., pyridine, picoline, lutidine, nicotine), a weakly basic anion exchange resin (e.g., those known under the trade marks Amberlite IR-45, IR-4B, Duorite A-4),a metal oxide, an alkali metal aliphatic or aromatic carboxylate (e.g., formate, acetate, phenylacetate, benzoate), or the like bases as far as the production of the objective material is not disturbed. (2) Rearrangement By the action of acid on 4-(leaving group substituted)-1-(alk-2-enyl)silyl-2-azetidinone ( III ) in an inert solvent (e.g., hydrocarbon, ether, ester, halohydrocarbon solvent), the intramolecular allylic rearrangement occurs to give the corresponding 4-(alk-2-enyl)-2-azetidinone ( IV ). Usually, the reaction at -40 to 40°C completes within a time between 1 and 24 hours. The yield is about 80 to 90 %. Here, the acid can preferably be 0.1 to 5 equivalents of a mineral acid (e.g., hydrochloric acid, phosphoric acid, sulfuric acid, nitric acid, perchloric acid), carboxylic acid (e.g., formic acid, acetic acid, malic acid, trifluoroacetic acid), sulfonic acid (e.g., methanesulfonic acid, trifluoromethanesulfonic acid, benzenesulfonic acid, toluenesulfonic acid, trifluoromethanesulfonic acid trimethylsilyl ester), Lewis acid (e.g., aluminum chloride, zinc chloride, zinc bromide, titanium chloride, stannic chloride, antimony chloride, cupper acetate) or the like. As is explained above, the C to C bond formation is a novel reaction specific to the intramolecular reaction of 4-leaving group substituted-1-(substituted or unsubstituted allyl)silyl-2-azetidinone, unattainable by the intermolecular reaction. [Reaction condition] The said synthetic reactions are carried out usually at -20 to 50°C for 10 minutes to 10 hours. It is carried out in a solvent, if required under anhydrous condition. Other conventional conditions can be applied similarly. The solvent for the reactions is, for example, hydrocarbon (e.g., pentane, hexane, octane, benzene, toluene, xylene), halogenohydrocarbon (e.g., dichloromethane, chloroform, carbon tetrachloride, dichloroethane, trichloroethane, chlorobenzene), ether (e.g., diethyl ether, methyl isobutyl ether, dioxane, tetrahydrofuran), ketone (e.g., acetone, methyl ethyl ketone, cyclohexanone), ester (e.g., ethyl acetate, isobutyl acetate, methyl benzoate), nitrohydrocarbon (e.g., nitromethane, nitrobenzene), nitrile (e.g., acetonitrile, benzonitrile), amide (e.g., formamide, acetamide, dimethylformamide, dimethylacetamide, hexamethylphosphorotriamide), sulfoxide (e.g., dimethylsulfoxide), carboxylic acid (e.g., formic acid, acetic acid, propionic acid), organic base (e.g., diethylamine, triethylamine, pyridine, picoline, collidine, quinoline), alcohol (e.g., methanol, ethanol, propanol, hexanol, octanol, benzyl alcohol), water, or the like industrial solvents or mixtures thereof. [Work up] The objective products can be obtained from the reaction mixture by removing contaminants (e.g., unreacted starting material by-products, solvent) in a conventional manner (e.g., extracting, evaporating, washing, concentrating, precipitating, filtering, drying) and isolated by a conventional work up (e.g., absorption, elution, distillation, precipitation, chromatography), or a combination of these. [Use] The product, 4-alkenyl-2-azetidinone, can be used for producing, at least some known antibacterials. Thus, 4-(alk-2-enyl)-2-azetidinone ( IV ) can be converted into 1β-methyl-2-(nucleophilic group substituted)methylcarbapenem ( VIII ) efficiently by the route as shown in the scheme on the next page wherein Het is 1,2,4-thiadiazolyl; R⁹ is 1-t-butyldimethylsilyloxyethyl; and R¹⁰ is p-nitrobenzyl in a representative case. Namely, 4-(alk-2-enyl)-2-azetidinone ( IV ) is treated with p-nitrobenzyl glyoxylate (1.5 equivalents) in tetrahydrofran in the presence of triethylamine at about 50°C for 3 hours to give glycolate ( V ). This is treated with m-chloroperbenzoic acid (2 equivalents) and sodium hydrogen carbonate (2 equivalents) giving epoxide which is then treated with thionlyl chloride (1.2 equivalents) and lutidine (3 equivalents) at -20°C for 1.5 hours in tetrahydrofuran, and then reacted with in dioxane with triphenylphosphine (1.2 equivalents) and lutidine (3 equivalents) at 60°C for 5 hours to give ylide ( VI ). This is reacted with 1,2,4-thiadiazolylthiol (3 equivalents) and butyllthium (0.5 equivalents) in tetrahydrofuran to give thiolate ( VII ). This is oxidized using dimethyl sulfoxide (3 equivalents), trifluoroacetic acid anhydride (2 equivalents), and triethylamine (4.5 equivalents) in dichloromethane to give the corresponding ketone and then the product is heated in toluene to form the carbapenem ring, and deesterified in dichloromethane with aluminum chloride to give 1β-methyl-2-(nucleophilic group substituted)-methylcarbapenem compound ( VIII ). The antibacterial potency of the objective 1β-methyl isomer is superior to that of the corresponding 1α-methyl isomer. Similarly, 4-(alk-2-enyl)-2-azetidinone ( IV ) can also be converted into sterically pure 1β-methyl-2-nucleophilic group substituted-carbapenem compound ( IX ). The following examples show the embodiment of this invention. In the NMR of a compound having more than one same type groups and when the chemical shifts of protons in them are different, the signal splits and the area ratio corresponds to number of the group and total area corresponds to number of the atoms. In this case each chemical shift is shown with comma and number of splitting and the mark " x " are given before the type of the signals. (Abbreviations) Ac = acetyl, tBu = t-butyl, Bz = benzoyl, Dioxolon-Et = 2-oxo-4-methyl-1,3-dioxol-4-yl, Et = ethyl, Me = methyl, Ms = mesyl, PMB = p-methoxybenzyl, PNB = p-nitrobenzyl, Ph = phenyl, Pro = propionyl, Tet = 1-methyltetrazol-5-yl, Tdz = thiadiazolyl, THP = tetrahdropyranyl, Tr = trityl, Ts = tosyl. Example 1 [Intermediates for producing 1β-methylcarbapenems from the 4-acetoxyazetidinone starting material] Example 1A To an ice cold solution of 3α-(1-(R)-t-butyldimethylsilyloxyethyl)-4β-acetoxyazetidin-2-one (10.01 g; 34.83 millimoles) and (Z)-crotyldimethylchlorosilane (5.71 g; 1.1 equivalents) in dichloroemethane (30 ml) are added dropwise triethylamine (5.6 ml; 1.15 equivalents) with stirring. After 30 minutes' stirring, the mixture is kept at room temperature overnight, diluted with hexane (300 ml) and precipitating triethylamine hydrochloride salt is removed by filtration. The filtrate is concentrated in vacuum to give 1-(Z)-crotyldimethylsilyl-3α-(1-(R)-t-butyldimethylsilyloxyethyl)-4β-acetoxyazetidin-2-one (14.0 g). NMR (EM-390, CDCl₃)δ: 0.07, 0.13, 0.25(3 x s, 12H), 0.89(s, 9H), 1.23(d, J=6.5Hz, 3H), 1.57(d, J=4.5Hz, 3H), 1.75(d, J=7Hz, 3H), 2.07 (s, 3H), 3.15(d-like, 1H), 4.21(m, 1H), 5.23∼5.57(m, 2H), 6.15(s, 1H) ppm. IR (Nujol)ν: 1756, 1750, 1654, 1260, 1236, 840 cm⁻¹. NMR (VR-200, CDCl₃)δ: 0.06, 0.08, 0.24, 0.27(4 x s, 12H), 0.88(s, 9H), 1.24(d, J= 6.4Hz, 3H), 1.58(d, J=5Hz, 3H), 1.75(d, J=7.2Hz, 2H), 2.09(s, 3H), 3.14(dd-like, 1H), 4.19(m, 1H), 5.31∼5.53(m, 2H), 6.14 (s, 1H) ppm. Example 1B To a solution of 3α-(1-(R)-t-butyldimethylsilyloxyethyl)-4β-acetoxy-1-(Z)-(crotyldimethylsilyl)azetidin-2-one (5.24 g; 13.1 millimoles) in dichloromethane (18 ml) at -20°C with stirring is dropwise added trifluoromethanesulfonic acid trimethylsilyl ester (1.26 ml; 0.5 equivalents). After 10 minutes, the mixture is kept at room temperature for 1.5 hours. The reaction mixture is poured into cold aqueous sodium hydrogen carbonate and the organic layer is separated, dried, and concentrated in vacuum. The residue is recrystallized from n-hexane to give 3α-(1-(R)-t-butyldimethylsilyloxyethyl)-4β-((R)-1-buten-3-yl)azetidin-2-one (2.81 g) showing physical constants identical with those of literatures. mp 142-142.5°C. Yield: 75.7 %. By chromatographic separation of the mother liquor on silica gel (Lober-B (registered trade mark) toluene/ethyl acetate = 2:1), further crystals of above product (130mg ; yield: 3.5%) from non-polar fraction and 3α-(1-(R)-t-butyldimethylsilyloxyethyl)-4β -((S)-1-buten-3-yl)-azetidin-2-one (1:1 mixture; 206mg; Yield: 5.6%). The latter mixture gives crystals of each isomers on repeated silica gel chromatography. NMR (VR-200, CDCl₃)δ : 0.07(s, 6H), 0.88 (s, 9H), 1.09(d, J=6.8 Hz, 3H), 1.18(d, J =6.2Hz, 3H), 2.33(m, 1H), 2.81 (brs, 1H), 3.50 (dd, J=7.5Hz, J=2.0Hz, 1H), 4.17(m, 1H), 5.05-5.15(m, 2H), 5.69-5.86(m, 1H), 5.97(brs, 1H) ppm. IR (Nujol)ν: 1758, 1712, 1642, 1051, 830 cm⁻¹. Example 1C (1 step reaction (1)) To a cold stirred solution of 3α -(1-(R)-t-butyldimethylsilyloxyethyl)-4β-acetoxyazetidin-2-one (900mg; 3.13 millimoles) and (Z)-crotyldimethylchlorosilane (560 mg; 1.2 equivalents) in dichloromethane (4.5 ml) is dropwise added triethylamine (0.53 ml) (1.2 equivalents). After keeping at room temperature overnight, zinc bromide (740 mg; 1.05 equivalents) is added to the reaction mixture and it is stirred at room temperature for 24 hours. The reaction mixture is poured into cold aqueous sodium hydrogen carbonate. The organic layer is separated, dried, and concentrated in vacuum. The crystals are recrystallized from acetonitrile to give 3α-(1-(R)-t-butyldimethylsilyloxyethyl)-4β-((R)-1-buten-3-yl)azetidin-2-one (355 mg). mp 140-142°C. Yield: 40.0 %. Example 2 [Intermediates for producing 1β-methylcarbapenems from 4-benzoyloxyazetidinone starting material] (1 step reaction (2)) To an ice cold stirred solution of 3α-(1-(R)-t-butyldimethylsilyloxyethyl)-4β-benzoyloxyazetidin-2-one (365 mg) and (Z)-crotyldimethylchlorosilane (185 mg; 1.2 equivalents) in a chloroform-benzene mixture (3 : 1; 1.5 ml) is dropwise added triethylamine (0.18 ml; 1.2 equivalents). After stirring at room temperature overnight, the solution is mixed with zinc bromide (243 mg) and stirred at room temperature for 24 hours. The reaction mixture is poured into aqueous sodium hydrogen carbonate. The organic layer is taken, dried, and concentrated in vacuum. The residue is crystallized from acetonitrile to give 3α-(1-(R)-t-butyldimethylsilyloxyethyl)-4β-((R)-1-buten-3-yl)-azetidin-2-one (178 mg). mp 140-142°C. Yield: 61.2 %. Example 3 [Intermediate for producing 1-unsubstituted carbapenems from 4-acetoxyazetidinone starting material] Example 3A A solution of 3α-(1-(R)-t-butyldimethylsilyloxyethyl)-4β-acetoxyazetidin-2-one (287mg; 1 millimoles), allyldimethylchloro silane 190mg (1.4 equivalents), and triethylamine (0.2 ml) in dichloromethane (2 ml) is kept at room temperature overnight. The reaction mixture is diluted with dichloromethane, washed with aqueous sodium hydrogen carbonate, dried, and concentrated in vacuum to give 3α-(1-(R)-t-butyldimethylsilyloxyethyl)-4β-acetoxy-1-(allyldimethylsilyl)azetidin-2-one (450 mg). NMR (VR-200, CDCl₃)δ: 0.06, 0.07, 0.26, 0.28(4 x s, 12H), 0.87(s, 9H), 1.23(d, J= 6.5Hz, 3H), 1.77(d, J=7Hz, 2H), 2.09(s, 3H), 3.15 (dd, J=3Hz, J=1.3Hz, 1H), 4.18 (m, 1H), 4.82-4.98(m, 2H), 5.66-5.88(m, 1H), 6.13(d, J=1.3Hz, 1H) ppm. IR (film)ν: 1740-1780, 1636, 1230, 840 cm⁻¹. Example 3B To a solution of 3α-(1-(R)-t-butyldimethylsilyloxyethyl)-4β-acetoxy-1-(allyldimethylsilyl)azetidin-2-one (450 mg) in dichloromethane (2 ml) is added trifluoromethanesulfonic acid trimethylsilyl ester (60 µl) under ice cooling. After stirring for 1 hour at room temperature, the reaction mixture is diluted with dichloromethane, washed with aqueous sodium hydrogen carbonate, dried, and concentrated to give 3α-(1-(R)-t-butyl-dimethylsilyloxyethyl)-4β-allylazetidin-2-one (240 mg) showing physical constants the same as those of literature. Yield: 90 %. Example 4 [Similar reactions] Under a condition similar to that of Examples from 1 to 3, 4-(leaving group substituted)-1-(alk-2-enyl)silyl-2-azetidinone ( III ) and 4-(alk-2-enyl)-2-azetidinone ( IV ) having the groups as given on Table 1 (1) to (3) below are prepared from the corresponding 4-(leaving group substituted)-2-azetidinone ( I ).

Claims: A process for preparing a 1-(alk-2-enyl)silyl-2-azetidinone of the following formula (III) : which comprises treating a 2-azetidinone of the following formula (I) with an (alk-2-enyl)halo-silane of the following formula (II) : wherein R is hydrogen or a optionally substituted alkyl group selected from : 1C to 8C alkyl; 1C to 8C hydroxyalkyl; 1C to 8C haloalkyl; 4C to 8C dioxolyl; the hydroxy in the said hydroxyalkyl being optionally protected by an hydroxy protective group selected from 1C to 8C acyl, oxycarbonyl which is a group of carbonic acid half ester, 2C to 8C ether forming group, 3C to 18C silyl and 7C to 19C reactive aralkyl; R1 is a leaving group selected from : hydroxy, optionally substituted 1C to 8C alkanoyloxy, wherein the alkyl part of the group is straight, branched or cyclic alkyl and the substituents are selected from straight, branched, or cyclic alkyl, alkenyl, alkinyl, aralkyl, aryl, heterocyclyl, carboxylic acyl, carbamoyl, carboxy, protected carboxy, cyano, amino, acylamino, guanidyl, ureido, alkylamino, dialkylamino, isothiocyano, isocyano, nitro, nitroso, hydroxy, alkoxy, aryloxy, hetero-cyclyloxy, cyanato, oxo, carboxylic acyloxy, sulfonic acyloxy, phosphoric acyloxy, mercapto, alkylthio, alkylsulfonyl, arylthio, arylsulfonyl, heterocyclylthio, heterocyclylsulfonyl, acylthio, thioxo, sulfo, sulfamoyl, halogen, silyl and stannyl; 7C to 15C aroyloxy, 1C to 8C alkylsulfinyl, 6C to 10C arylsulfinyloxy, 1C to 8C alkylsulfonyloxy, 6C to 10C arylsulfonyloxy, 1C to 15C acyloxy and halogen; R² and R³ each is hydrogen or an optionally substituted 1C to 8C alkyl or 6C to 8C monocyclic aryl group, wherein the alkyl part of the said alkyl is straight, branched or cyclic alkyl and the substituents of said alkyl or aryl group are selected from halogen, nitrile, isonitrile, hydroxy, 1C to 8C alkoxy, 6C to 10C aryloxy, 1C to 10C acyloxy, 7C to 19C aralkoxy, oxo, 6C to 10C arylthio, 1C to 8C alkylthio, amino, 1C to 8C mono- or di-alkylamino, tetrazol-1-yl, triazol-1-yl, 1C to 10C mono-or poly-cyclic arylinio; R⁴ is hydrogen, 1C to 8C alkyl or a 1C to 8C alkyl substituted by a nucleophilic group selected from : halogen, hydroxy, 1C to 8C alkoxy, 6C to 10C aryloxy, 1C to 10C acyloxy, 7C to 19C aralkoxy, oxo, 6C to 10C arylthio, 1C to 8C alkylthio, amino, 1C to 8C mono or di-alkylamino, tetrazol-1-yl, triazol-1-yl, 1C to 8C mono or poly-cyclic arylinio, 1C to 8C alkyl, 3C to 12C alkenyl, 7C to 19C aralkyl, 6C to 12C aryl, carboxy, 1C to 8C alkoxycarbonyl, 3C to 12C alkenyloxycarbonyl, 8C to 20C aralkoxy-carbonyl, 6C to 12C aryloxycarbonyl, 1C to 12C aminooxycarbonyl, 3C to 12C silyloxycarbonyl, 3C to 12C stannyloxycarbonyl, 2C to 15C 1-oxygenated alkoxycarbonyl, 3C to 15C 1-alkoxycarbonyloxyalkyl, 2C to 8C alkoxyakyl and 4C to 8C 2-oxacycloalkyl; R⁵ and R⁶ each is hydrogen; optionally substituted 1C to 10C alkyl, or optionally substituted mono or di-cyclic 5 to 6 membered carbo- or heterocyclic aryl group, wherein the alkyl part of the said alkyl group is straight, branched or cyclic and the substituents of said alkyl or aryl group are selected from straight, branched, or cyclic alkyl, alkenyl, alkinyl, aralkyl, aryl, heterocyclyl, carboxylic acyl, carbamoyl, carboxy, protected carboxy, cyano, amino, acylamino, guanidyl, ureido, alkylamino, dialkylamino, isothiocyano, isocyano, nitro, nitroso, hydroxy, alkoxy, aryloxy, heterocyclyloxy, cyanato, oxo, carboxylic acyloxy, sulfonic acyloxy, phosphoric acyloxy, mercapto, alkylthio, alkylsulfonyl, arylthio, arylsulfonyl, heterocyclylthio, heterocyclylsulfonyl, acylthio, thioxo, sulfo, sulfamoyl and from halogen, silyl and stannyl; carboxy or a protected carboxy group selected from chloroethyl ester, methanesulfonylethyl ester, aralkyl ester, alkenyl ester and ester forming protected carboxy; R⁷ and R⁸ each is hydrogen, optionally substituted 1C to 8C alkyl or optionally substituted 1C to 10C mono- or di-cyclic 5 to 6 membered carbo- or hetero-cyclic aryl group, wherein the alkyl part of said alkyl group is straight, branched or cyclic alkyl and the substituents of said alkyl or aryl group are selected from straight, branched, or cyclic alkyl, alkenyl, alkinyl, aralkyl, aryl, heterocyclyl, carboxylic acyl, carbamoyl, carboxy, protected carboxy, cyano, amino, acylamino, guanidyl, ureido, alkylamino, dialkylamino, isothiocyano, isocyano, nitro, nitroso, hydroxy, alkoxy, aryloxy, heterocyclyloxy, cyanato, oxo, carboxylic acyloxy, sulfonic acyloxy, phosphoric acyloxy, mercapto, alkylthio, alkylsulfonyl, arylthio, arylsulfonyl, heterocyclylthio, heterocyclylsulfonyl, acylthio, thioxo, sulfo, sulfamoyl and from halogen, silyl and stannyl; and Hal is halogen or a pseudo halogen; and wherein R², R³, R⁴, R⁵ and R⁶ can be combined directly or through a hetero atom to form a part of cyclic structure. A process as claimed in Claim 1 wherein the reaction is carried out in the presence of 1 to 5 equivalents of a base e.g., tri(1C to 8C alkyl)amine, aromatic base, weakly basic anion exchange resin, metal oxide, aliphatic or aromatic carboxylate. A process as claimed in Claim 1 wherein the reaction is carried out with 1 to 2 equivalents of (alk-2-enyl)halosilane of the formula (II) specified in claim 1. A process as claimed in Claim 1 wherein the reaction is carried out at a temperature in a range between -20 and 40°C. A process as claimed in Claim 1 wherein the reaction is carried out over a 30 minutes to 25 hours period. A process for preparing a 4-(alk-2-enyl)-2-azetidinone of the following formula ( IV ) which comprises treating a 1-(alk-2-enyl)silyl-2-azetidinone of the formula (III) specified in claim 1 with acid in an inert solvent wherein R, R², R³, R⁴, R⁵ and R⁶ are as defined in claim 1. A process as claimed in Claim 6 wherein the reaction is carried out with 0.1 to 5.0 equivalents of a mineral acid, carboxylic acid, sulfonic acid, or Lewis acid. A process as claimed in Claim 6 wherein the reaction is carried out at between -40 and 40°C. A process as claimed in Claim 6 wherein the reaction is carried out over 1 to 24 hours. A 1-(alk-2-enyl)silyl-2-azetidinone of the following formula (III). wherein R, R¹, R², R³, R⁴, R⁵, R⁶, R⁷, and R⁸ are as defined in Claim 1. A compound as claimed in Claim 10 wherein R is 1C to 8C alkyl, 1C to 8C haloalkyl, or protected 1C to 8C 1-hydroxyalkyl. A compound as claimed in Claim 10 wherein R is methyl, ethyl, propyl, isopropyl, haloethyl, acetoxymethyl, acetoxyisopropenyl, trialkylsilyloxymethyl, or trialkylsilyloxyethyl. A compound as claimed in Claim 10 wherein R is trimethylsilyloxyethyl or tertbutyldimethylsilyloxyethyl. A compound as claimed in Claim 10 wherein R¹ is 1C to 15C acyloxy or halogen. A compound as claimed in Claim 10 wherein R¹ is acetoxy or benzoyloxy. A compound as claimed in Claim 10 wherein R² and R³ each is hydrogen, 1C to 8C alkyl, or phenyl. A compound as claimed in Claim 10 wherein R² and R³ each is hydrogen or methyl. A compound as claimed in Claim 10 wherein R⁴ is hydrogen, 1C to 8C alkyl or a 1C to 8C alkyl substituted by halogen, oxo, monocylic heterocyclylthio, hydroxy, 1C to 8C alkoxy, 6C to 10C aryloxy, 7C to 19C aralkoxy, 1C to 10C acyloxy, carboxy, or carboxy protected by 1C to 8C alkyl, 2C to 12C alkenyl, 7C to 15C aralkyl, or 6C to 12C aryl as an ester. A compound as claimed in Claim 10 wherein R⁵, R⁶, R⁷, and R⁸ each is hydrogen, 1C to 8C alkyl, or phenyl. A compound as claimed in Claim 10 wherein R⁵, R⁶, R⁷, and R⁸ each is hydrogen or methyl.

Inventors: UYEO SHOICHIRO IZUTSUYA-CHO, UYEO, SHOICHIRO 407, IZUTSUYA-CHO
Applicants: SHIONOGI & CO, SHIONOGI SEIYAKU KABUSHIKI KAISHA
Application year: 1988
Main classification: C07F7
IPC codes: C07D205, C07F7